纳米制剂有限公司获得美国眼睛和大脑药物输送技术专利. Nanomerics Ltd. secures US patent for eye and brain drug delivery tech.

总部位于英国的Nanomerics Ltd.获得了一项美国专利,将其分子包膜技术 (MET) 平台的知识产权保护延长到2040年代. UK-based Nanomerics Ltd. has secured a U.S. patent extending intellectual property protection for its Molecular Envelope Technology (MET) platform into the 2040s. 这种生物相容的聚合物技术可提高药物的输送到眼睛和大脑,支持过敏结膜炎,青光斑以及视网膜疾病的临床候选者, 以及治疗疼痛和. This biocompatible polymer technology enhances drug delivery to the eye and brain, supporting clinical candidates for allergic conjunctivitis, glaucoma, and retinal diseases, as well as treatments for pain and epilepsy.